Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Health Catalyst, Inc.    HCAT

HEALTH CATALYST, INC.

(HCAT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Catalyst to Participate in Upcoming Investor Conferences

11/24/2020 | 04:30pm EST

SALT LAKE CITY, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, President, Bryan Hunt, CFO and Adam Brown, SVP of Investor Relations and FP&A, will participate in the following upcoming investor conferences:

  • Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020, which will include a fireside chat presentation. An audio-only recording will be available at https://ir.healthcatalyst.com/investor-relations.
  • Evercore ISI HealthCONx Conference on Thursday, December 3, 2020, which will include a fireside chat presentation at 4:20 p.m. EST.
  • Guggenheim Digital Health Virtual Conference which will include a fireside chat presentation on Tuesday, December 8, 2020 at 3:15 p.m. EST, as well as one-on-one meetings on Wednesday, December 9, 2020.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Health Catalyst Investor Relations Contact:

Adam Brown
Senior Vice President, Investor Relations and FP&A
+1 (855)-309-6800
ir@healthcatalyst.com

Health Catalyst Media Contact:

Kristen Berry
Vice President, Public Relations
+1 (617) 234-4123
+1 (774) 573-0455 (m)
kberry@we-worldwide.com

 


Primary Logo


© GlobeNewswire 2020
All news about HEALTH CATALYST, INC.
01/19BUSINESS RADIO X : Trudy Sullivan Interview
PU
01/18HEALTH CATALYST : Becker's Healthcare CEO + CFO Forum
PU
01/13HEALTH CATALYST : Named a Glassdoor Best Places to Work for the Fourth Time in S..
PU
01/13HEALTH CATALYST : Re-Certified as a Great Place to Work Company
PU
01/07HEALTH CATALYST : Data Bridge the Knowledge Gaps in the Fight Against COVID-19
PU
01/07TRANSFORMATION CAPITAL : Launches $500 Million Digital Health Fund to Support En..
PR
2020Health Catalyst to Participate in Upcoming Investor Conference
GL
2020HEALTH CATALYST : Utah Companies Recognized for Leadership, Training and Creativ..
PU
2020HEALTH CATALYST : As Pfizer Vaccine Gets Emergency Approval, Experts Say It's Ti..
PU
2020HEALTH CATALYST : Farhana Nakhooda COVID-19 Role of Data Interview (Channel News..
PU
More news
Financials (USD)
Sales 2020 188 M - -
Net income 2020 -91,8 M - -
Net cash 2020 96,9 M - -
P/E ratio 2020 -21,4x
Yield 2020 -
Capitalization 2 181 M 2 181 M -
EV / Sales 2020 11,1x
EV / Sales 2021 9,31x
Nbr of Employees 1 000
Free-Float 95,1%
Chart HEALTH CATALYST, INC.
Duration : Period :
Health Catalyst, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HEALTH CATALYST, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Average target price 44,85 $
Last Close Price 51,33 $
Spread / Highest target -2,59%
Spread / Average Target -12,6%
Spread / Lowest Target -27,9%
EPS Revisions
Managers and Directors
NameTitle
Daniel D. Burton Chief Executive Officer & Director
Patrick J. Nelli President
Paul Horstmeier Chief Operating Officer
Bryan Hunt Chief Financial Officer
Holly Rimmasch Chief Clinical Officer
Sector and Competitors
1st jan.Capitalization (M$)
HEALTH CATALYST, INC.17.92%2 181
THERMO FISHER SCIENTIFIC10.48%203 954
DANAHER CORPORATION7.16%169 098
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.12.25%89 689
INTUITIVE SURGICAL, INC.-9.05%87 471
ILLUMINA, INC.9.80%59 313